Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

Clinical trial NCT04547777 · RECRUITING

Trial details

NCT number: NCT04547777
Sponsor: Darell Bigner
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma, Malignant

Start date: 2021-07-09
Primary completion: 2027-06-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.